Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 14 Feb 2023 for Lineage Cell Therapeutics, Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Gary S. Hogge: trading record in brief
This profile gathers the share dealings of Gary S. Hogge in Lineage Cell Therapeutics, Inc. Over a trading history stretching from 28 December 2021 to 11 February 2023, the count stands at 2 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 14 February 2023 came the latest disclosure, an option exercise in Lineage Cell Therapeutics, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Gary S. Hogge
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
13,020 sharesCommon Shares, no par valueSEC:0001493152-23-004895:0
185,000 shares@ US$0.6919100.0% of flowCommon Shares, no par valueSEC:0001493152-21-032897:0
2 of 2 declarations
